Module 3 - Atrial fibrillation (AF) burden and stroke: implications in clinical practice

Return to Enrollment Page

OVERVIEW

In this module, we will review the latest information on the relationship between AF, AF burden and stroke. The implications of these findings on clinical practice, including screening and anticoagulation, will be explored.

FACULTY

Professor Giuseppe Boriani, MD, PhD, FEHRA, FESC

Doctor of Philosophy (PhD) in Cardiovascular Physiopathology at the University of Milan, Italy.
Professor of Cardiology at the University of Modena and Reggio Emilia and Chief of Cardiology at Modena University Hospital.
Director of the Post-Graduate School of Cardiovascular Diseases at the University of Modena and Reggio Emilia.

Graduation in Medicine and Specialization in Cardiology at the University of Bologna, Italy. 

Doctor of Philosophy (PhD) in Cardiovascular Physiopathology at the University of Milan, Italy. 

Professor of Cardiology at the University of Modena and Reggio Emilia and Chief of Cardiology at Modena University Hospital.  

Director of the Post-Graduate School of Cardiovascular Diseases at the University of Modena and Reggio Emilia.

Former member of the Board of the European Heart Rhythm Association and Chair of the Health Economics Committee (2009-2013). 

Fellow of the European Society of Cardiology and the European Heart Rhythm Association. 

Member of the Heart Rhythm Society.  

President (2016-2018) of AIAC (the Italian Society of Cardiac Pacing and Arrhythmology).

Scientific activity focused on clinical electrophysiology, pacemakers, implantable defibrillators, cardiac resynchronization therapy, atrial fibrillation, antiarrhythmic drugs, heart failure, ischemic heart disease, health economics and clinical cardiology. 

Member of the Editorial board of the European Heart Journal, European Journal of Heart Failure, Heart, and the European Journal of Internal Medicine.

Executive editor of EP Europace.

LEARNING OBJECTIVES

1.
Review the rationale for assessing atrial fibrillation (AF) burden with a risk-stratification approach
2.
Discuss how the concept of AF burden translates into clinical practice, particularly regarding the identification and management of patients at risk of stroke

GENERAL INFORMATION

Faculty Disclosure:

Giuseppe Boriani, MD, PhD, FEHRA, FESC

  • Consulting and speaker honoraria: Bayer, Boehringer Ingeheim, Boston Scientific,Daiichi Sankyo, Janssen, Sanofi.